Cargando…
Role of Multidrug Resistance Proteins in Nonresponders to Immunomodulatory Therapy for Noninfectious Uveitis
PURPOSE: Nearly a third to half of patients with noninfectious uveitis (NIU) fail to achieve control with immunomodulatory therapy (IMT). Multidrug resistance (MDR) proteins are transmembrane proteins that allow efflux of intracellular drugs, leading to drug resistance. The aim of our study was to c...
Autores principales: | Tagirasa, Ravichandra, Rana, Khokan, Kaza, Hrishikesh, Parai, Debaprasad, Damera, Santhoshkumar, Basu, Soumyava |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401954/ https://www.ncbi.nlm.nih.gov/pubmed/32821484 http://dx.doi.org/10.1167/tvst.9.5.12 |
Ejemplares similares
-
Intraocular therapy in noninfectious uveitis
por: Modugno, Rocco Luigi, et al.
Publicado: (2021) -
A Network of Serum Proteins Predict the Need for Systemic Immunomodulatory Therapy at Diagnosis in Noninfectious Uveitis
por: Kuiper, Jonas J.W., et al.
Publicado: (2022) -
Biologics for the treatment of noninfectious uveitis
por: Lin, Chang-Ping
Publicado: (2018) -
LV Prasad Eye Institute EyeSmart electronic medical record-based analytics of big data: LEAD-Uveitis Report 1: Demographics and clinical features of uveitis in a multi-tier hospital based network in Southern India
por: Tyagi, Mudit, et al.
Publicado: (2022) -
Pediatric Noninfectious Uveitis in a Tertiary Referral Center in Jordan: Clinical Spectrum and Immunomodulatory Treatment
por: Alzyoud, Raed, et al.
Publicado: (2022)